Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: Low erythrocyte CR1 expression is an acquired phenomenon-Reference-Cited by-同舟云学术

Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: Low erythrocyte CR1 expression is an acquired phenomenon

Published:1995-10 Issue:5 Volume:73 Page:457-462
ISSN:0818-9641
Container-title:Immunology and Cell Biology
language:en
Short-container-title:

Author:

KUMAR AMIT,KUMAR ASHOK,SINHA SUBRATA,KHANDEKAR PS,BANERJEE KAKOLI,SRIVASTAVA LM

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/icb199571.pdf

Reference35 articles.

1. Physiological and pathological aspects of circulating immune complexes;Schifferli;Kidney Int.,1989

2. Diagnostic significance of hypocomplementemia;Hebert;Kidney Int.,1991

3. The role of hypocomplementemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans;Schifferli;Clin. Exp. Immunol.,1989

4. In vivo handling of soluble complement fixing Ab-dsDNA immune complexes in chimpanzees;Kimberly;J. Clin. Invest.,1989

5. Kupffer cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat liver endothelial cells;Bogers;Clin. Exp. Immunol.,1991

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CR1 exon variants are associated with lowered CR1 expression and increased susceptibility to SLE in a Plasmodium falciparum endemic population;Lupus Science & Medicine;2016-11

2. Complement Component (3b/4b) Receptor 1 (CR1);Genetic Variants in Alzheimer's Disease;2013

3. Complement Receptor 1 Variants Confer Protection from Severe Malaria in Odisha, India;PLoS ONE;2012-11-13

4. Complement Receptor 1 (A3650GRsaI and Intron 27HindIII) Polymorphisms and Risk of Gallbladder Cancer in North Indian Population;Scandinavian Journal of Immunology;2009-12

5. Complement Receptor 1: Disease associations and therapeutic implications;Molecular Immunology;2009-02